Actinic Keratoses: Clinical Trials

98 trials for Actinic Keratoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

63 completed, 9 unknown, 6 active not recruiting, 6 terminated. 27 Not applicable, 17 Phase 4, 16 Phase 3, 14 Phase 2, 12 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable27Completed 17, Unknown 4, Recruiting 3, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 417Completed 11, Terminated 2, Active not recruiting 1, Enrolling by invitation 1, Unknown 1, Withdrawn 1
Phase 316Completed 14, Not yet recruiting 1, Terminated 1
Phase 214Completed 6, Unknown 3, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Phase 112Completed 9, Not yet recruiting 1, Recruiting 1, Unknown 1
Early Phase 12Completed 1, Terminated 1

Follow Actinic Keratoses: new trials by email Literature Review of Actinic Keratoses trials Research Report on Actinic Keratoses

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead
Cryotherapy + Tirbanibulin - Keratosis, Actinic Keratoses
Phase 3Not yet recruitingUniversity Hospital, Lille592026-11-302026-05-22
5-Fluorouracil and Calcipotriene for Field Treatment of Actinic Keratoses
Combination field therapy with 5-fluorouracil and calcipotriene (5FU/C) - Actinic Keratoses
Phase 1Not yet recruitingCedars-Sinai Medical Center962026-09-012026-10-05
PDT vs Peels for Treatment of Actinic Keratoses
Photodynamic Therapy, Chemical Peels - Actinic Keratoses
Phase 2Not yet recruitingNorthwestern University602026-08-012026-07-01
Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum
5% 5-fluorouracil (5-FU) powder, 5% 5-fluorouracil (5-FU) powder PLUS 15% Aluminum Chloride Hexahydrate (ACH) - Actinic Keratoses
Phase 1RecruitingWest Virginia University322026-02-062026-04-22
Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
Calcipotriol Only Product in Cutaneous Dose Form, Vaseline, Topical 5FU - Immunotherapy, Cutaneous Squamous Cell Carcinoma
Phase 2WithdrawnMassachusetts General Hospital2026-01-012025-05-07
Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
Calcipotriol Only Product in Cutaneous Dose Form, Vaseline, Topical 5FU - Cutaneous Squamous Cell Carcinoma, Actinic Keratoses
Phase 2WithdrawnMassachusetts General Hospital2026-01-012025-05-07
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
Ameluz, Sciton HEROic - Actinic Keratoses, Photodamage
Phase 1CompletedSherrif Ibrahim102025-06-272026-01-02
Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic Keratoses
5-FU (fluorouracil), Calcipotriol - Actinic Keratosis of Face and Scalp, Actinic Keratoses
Not applicableNot yet recruitingSt Vincent's University Hospital, Ireland502025-01-012024-11-12
Methyl Aminolevulinate 8% and 16% Incubated by 1 and 3 for Actinic Keratoses Treatment
light curettage, Pre irradiation of 1 hour, Pre irradiation of 3 hour - Actinic Keratoses
Not applicableCompletedUniversity of Nove de Julho42024-11-302026-07-29
Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis
5FU-Calcipotriol, 5-FU 50 MG/ML Topical Cream - Actinic Keratoses
Phase 4CompletedMaastricht University Medical Center2322024-09-042026-10-29
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
Topical Aminolevulinate, Photodynamic therapy (PDT), Red light illumination - Actinic Keratoses
Phase 2CompletedCase Comprehensive Cancer Center142024-08-252026-02-20
Efficacy And Safety Of Illumination Dose Reduction In Red Light Photodynamic Therapy For Actinic Keratoses
Half-dose illumination protocol, Full-dose illumination protocol - Actinic Keratoses
Not applicableUnknownFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal202024-08-012024-08-09
Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis
Cryotherapy, 5Fluorouracil - Actinic Keratoses
Phase 4Enrolling by invitationUniversity of California, Davis732024-07-012026-07-06
Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
AI-based medical device for aided diagnosis in dermatological conditions - Skin Lesions, Melanocytic Nevi
CompletedAI Labs Group S.L92024-06-042026-02-24
Investigation of the Effect of Lipikar Baume AP+M
Lipikar Baume AP+M - Actinic Keratoses
Not applicableRecruitingCentroDerm GmbH202024-04-232025-07-11
Effect of Lipikar Urea 30% Before Actinic Keratoses Treatment
Group A: holistic approach, Group B: TolakĀ® Standard of use - Actinic Keratoses
Not applicableUnknownCosmetique Active International1002024-04-052024-06-18
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
Fractionated Laser Resurfacing - Actinic Keratoses, Aging
Not applicableRecruitingWright State University802024-03-202026-07-16
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
OCT (Optical Coherence Tomography) - Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorder
RecruitingUniversity of Palermo2002024-03-132025-05-23
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands
Tirbanibulin - Actinic Keratoses
Phase 4WithdrawnMedical University of Graz2023-10-012024-05-30
Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis
Cream containing madecassoside and 5 % panthenol, Daylight PDT - Actinic Keratoses
Not applicableCompletedMerete Haedersdal202023-09-272024-05-08

Showing 20 of 98. Sign in to see all of them.

Narrower conditions

Keratosis, Actinic (98)  ·  Carcinoma, Squamous Cell (8)  ·  Carcinoma, Basal Cell (4)  ·  Skin Diseases (4)  ·  Skin Neoplasms (4)  ·  Melanoma (3)  ·  Keratosis (2)  ·  Precancerous Conditions (2)  ·  Actinic cheilitis (1)  ·  Bowen's Disease (1)  ·  Disease (1)  ·  Graft vs Host Disease (1)  ·  Health Behavior (1)  ·  Hidradenitis Suppurativa (1)  ·  Leukoplakia, Oral (1)

Broader conditions

Skin and Connective Tissue Diseases (98)  ·  Neoplasms (97)  ·  Keratosis (96)  ·  Precancerous Conditions (96)  ·  Skin Diseases (94)  ·  Neoplasms by Histologic Type (12)  ·  Carcinoma (11)  ·  Neoplasms, Glandular and Epithelial (11)  ·  Neoplasms, Squamous Cell (9)  ·  Neoplasms by Site (8)  ·  Neoplasms, Basal Cell (4)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neuroectodermal Tumors (3)  ·  Neuroendocrine Tumors (3)

Interventions

Fluorouracil (13)  ·  Photochemotherapy (10)  ·  Aminolevulinic Acid (9)  ·  Imiquimod (8)  ·  methyl 5-aminolevulinate (8)  ·  3-ingenyl angelate (5)  ·  Cryotherapy (4)  ·  Gels (4)  ·  Petrolatum (4)  ·  calcipotriene (3)  ·  1-phenyl-3,3-dimethyltriazene (2)  ·  BF-200 ALA (2)  ·  Diclofenac (2)  ·  Niacinamide (2)  ·  Phototherapy (2)

Sponsors

Maastricht University Medical Center (6)  ·  Galderma R&D (4)  ·  Northwestern University (4)  ·  Peplin (4)  ·  University of California, Davis (3)  ·  Bispebjerg Hospital (2)  ·  Encube Ethicals Pvt. Ltd. (2)  ·  Graceway Pharmaceuticals, LLC (2)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  Massachusetts General Hospital (2)  ·  Medical University of Graz (2)  ·  Merete Haedersdal (2)  ·  Novoxel Ltd. (2)  ·  Shanghai Dermatology Hospital (2)  ·  St Vincent's University Hospital, Ireland (2)

Countries

United States (39)  ·  Germany (13)  ·  Netherlands (9)  ·  Denmark (6)  ·  Australia (5)  ·  France (5)  ·  United Kingdom (4)  ·  Austria (3)  ·  Belgium (3)  ·  Italy (3)  ·  Spain (3)  ·  Brazil (2)  ·  China (2)  ·  Israel (2)  ·  Sweden (2)

Top investigators

Klara Mosterd, prof.dr. (4)  ·  Murad Alam, MD (4)  ·  Assi Levi, MD (2)  ·  Janelle Katsamas (2)  ·  Shadmehr Demehri, MD/PHD (2)  ·  Alexandra Geusau, Prof. Dr. (1)  ·  Andrew McGovern, MD (1)  ·  Antonio Martorell, PhD (1)  ·  Barry Galitzer, MD (1)  ·  Bibiana Perez Garcia, MD (1)  ·  Charlotte Proby, MBCHB (1)  ·  Christine M. Winslow, Ph.D. (1)  ·  Claas Ulrich, MD (1)  ·  Claus Garbe, Prof. Dr. (1)  ·  Daniel Eisen, MD (1)

Results publications

PMID 22417254, PMID 25950503, PMID 17488399, PMID 17488400, PMID 20133013, PMID 21283921, PMID 22136038, PMID 22329784, PMID 24033340, PMID 24037822, PMID 24589500, PMID 24818175, PMID 25124939, PMID 25174261, PMID 25561207, PMID 26011755, PMID 26300464, PMID 26843523, PMID 26921093, PMID 27167413, PMID 27375183, PMID 27453064, PMID 27500794, PMID 27672408, PMID 28489298, PMID 28532759, PMID 29070025, PMID 29427796, PMID 30868672, PMID 30887613, PMID 31334125, PMID 31736123, PMID 31955461, PMID 32387665, PMID 33567191, PMID 34428179, PMID 34633154, PMID 34743007, PMID 36198452, PMID 36232651, PMID 37146674, PMID 38495115, PMID 40047786, PMID 6567734

NIH funding

2016 (1), R44CA250727 (1)